Product information

Current status:

Marketed

Current status date:

2024-06-11

Original market date: ^{See footnote 1}

2012-10-01

Product name:

ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP

Description:

FOR USE WITH APHERESIS DEVICES ONLY. NOT FOR DIRECT I.V. INFUSION.

DIN:

02377411 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

0-Unassigned

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.04.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:^{See footnote5}

0153063001